Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cranial Nerve Diseases × Ferrosoferric Oxide × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Urinary Bladder Neoplasms 1 Pancreatic carcinoma, familial 1 Pancreatic Intraductal Neoplasms 1 Cranial Nerve Diseases 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1

Interventions

prednylidene 1 exifone 1 deltacortene 1 Prednisone 1 Methylprednisolone 1 Medrol Veriderm 1 Magnetic Resonance Spectroscopy 1 Gadolinium 1 Ferrosoferric Oxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03270059 2026-02-27

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

OHSU Knight Cancer Institute

Phase 2 Recruiting

Brain Neoplasms, Cranial Nerve Diseases, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡